Samer Al-Hadidi

Researcher

Last publication 2024 Last refreshed 2026-05-16

unknown

2 h-index 4 pubs 14 cited

Biography and Research Information

OverviewAI-generated summary

Samer Al-Hadidi's research focuses on comparing therapeutic approaches for myelofibrosis, specifically investigating upfront allogeneic transplantation against Janus kinase (JAK) inhibitor therapy. This work has involved a North American collaborative effort, with findings published in 2023 and a correction noted in 2024. Al-Hadidi also studies the management of multiple myeloma, with recent work examining the role of vertebral augmentation procedures. His scholarship metrics include an h-index of 2, with 4 total publications and 13 citations. Key collaborators include Nishanth Thalambedu and Mudassar Kamran, both from the University of Arkansas for Medical Sciences, with whom he shares one publication each. Al-Hadidi's recent activity indicates ongoing engagement in his research areas.

Metrics

  • h-index: 2
  • Publications: 4
  • Citations: 14

Selected Publications

  • The Role of Vertebral Augmentation Procedures in the Management of Multiple Myeloma (2024)
    6 citations DOI OpenAlex
  • Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study (2024)
  • Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study (2023)
    7 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

23 Collaborators 17 Institutions 2 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics